Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 24.19 M26.91 M26.73 M27.28 M27.62 M 108.54 M Research & development 3.93 M4.12 M4.52 M4.47 M3.91 M 17.01 M Operating income -9.48 M-9.65 M-9.93 M-10.03 M-9.61 M -39.23 M Non-Operating Income, Total 690 K-2.09 M3.4 M2.64 M290 K 4.24 M Interest expense, net of interest capitalized 583 K618 K526 K634 K432 K 2.21 M Non-Operating Income, excl. Interest Expenses 990 K848 K2.88 M2.72 M2.66 M 9.11 M Unusual income/expense -300 K-2.94 M525 K-87 K-2.37 M -4.87 M Pretax income -8.79 M-11.74 M-6.53 M-7.39 M-9.32 M -34.99 M Equity in earnings ————— — Taxes 234 K274 K165 K1.13 M108 K 1.67 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -9.03 M-12.01 M-6.7 M-8.52 M-9.43 M -36.66 M Discontinued operations -2.95 M117.19 M-247 K566 K-1.11 M 116.4 M Net income -11.98 M105.18 M-6.94 M-7.96 M-10.54 M 79.74 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -13.98 M103.18 M-8.94 M-9.96 M-12.54 M 71.74 M Basic earnings per share (Basic EPS) -0.282.05-0.18-0.19-0.25 1.43 Diluted earnings per share (Diluted EPS) -0.282.05-0.18-0.19-0.25 1.43 Average basic shares outstanding 49.95 M50.26 M50.13 M50.07 M49.9 M — Diluted shares outstanding 49.95 M50.26 M50.13 M50.07 M49.9 M — EBITDA -1.84 M-2.35 M-3.52 M-1.39 M-3.21 M -10.47 M EBIT -9.48 M-9.65 M-9.93 M-7.74 M-9.61 M -36.94 M Cost of revenue 22.4 M24.08 M22.91 M23.74 M25.89 M 96.61 M Other cost of goods sold —7.6 M6.4 M7 M8.1 M 29.1 M Depreciation & amortization (cash flow) 7.65 M7.3 M6.42 M6.36 M6.4 M 26.47 M